Related Experiment Video
Updated: Jun 20, 2025

08:48
Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
6.9K
Recurrent Fungemia Due to Candida auris
Emma M Griffith1, Christopher Marsalisi1, Jorge Verdecia2
1Internal Medicine, University of Florida College of Medicine-Jacksonville, Jacksonville, USA.
Cureus
|July 18, 2024
Summary
Recurrent multidrug-resistant Candida auris (C. auris) infections pose significant challenges. This case highlights the difficulties in managing invasive C. auris, emphasizing its resistance and high mortality risk.
Area of Science:
- Infectious Diseases
- Mycology
- Critical Care Medicine
Background:
- Candida auris (C. auris) is an emerging multidrug-resistant fungal pathogen.
- Invasive C. auris infections are associated with high morbidity and mortality.
- Management of C. auris requires careful consideration of limited treatment options.
Observation:
- A case of recurrent, multidrug-resistant C. auris fungemia is presented.
- The patient experienced multiple hospitalizations and intensive care unit admissions over 12 months.
- Septic and hypovolemic shock complicated the management of C. auris fungemia.
Findings:
- Despite isolation and antifungal therapy, C. auris fungemia recurred.
- The case underscores the challenges posed by multidrug-resistant C. auris.
- Invasive C. auris infections demonstrate profound clinical implications.
Implications:
- This case highlights the need for enhanced surveillance and infection control for C. auris.
- Limited treatment options for multidrug-resistant C. auris contribute to poor outcomes.
- Further research is needed to develop effective therapeutic strategies against C. auris.
Keywords:
anti-microbial resistancecandida auriscandidemiafungemiaimmunocompromised patientsinfection prevention and control
